ID

16730

Descripción

Sponsor: OSI Pharmaceuticals Information provided by (Responsible Party): Astellas Pharma Inc (OSI Pharmaceuticals) A multicenter, randomized, double-blind, placebo-controlled, phase 3 study of single-agent Tarceva® (erlotinib) following complete tumor resection with or without adjuvant chemotherapy in patients with stage IB-IIIA non-small cell lung carcinoma who have EGFR-positive tumors. See https://clinicaltrials.gov/ct2/show/NCT00373425 Part of study: Concomitant Medications

Link

https://clinicaltrials.gov/ct2/show/NCT00373425

Palabras clave

Versiones (2)
  1. 2/8/16 2/8/16 -
  2. 3/8/16 3/8/16 - Julian Varghese
Subido en

3 de agosto de 2016

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Concomitant Medications, Tarceva in NSCLC patients who have EGFR-positive tumors DRKS00001485 NCT00373425

Inglés

Concomitant Medications, Tarceva in NSCLC patients who have EGFR-positive tumors NCT00373425

1 formularios  
Concomitant Medications
Descripción

Concomitant Medications

Concomitant Medication
Descripción

Concomitant Medication

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2347852
Medications
Descripción

Medications

Medication (Use generic name when possible)
Descripción

Concomitant Medication

Tipo de datos

text

Alias
UMLS CUI [1]
C2347852
Prophylaxis
Descripción

Indication Prophylaxis

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C2826696
UMLS CUI [1,2]
C0199176
Indication
Descripción

Indication

Tipo de datos

text

Alias
UMLS CUI [1]
C2826696
Date started: Prestudy
Descripción

Concomitant Medication Start Date

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2826734
Date started
Descripción

Concomitant Medication Start Date

Tipo de datos

date

Alias
UMLS CUI [1]
C2826734
Date stopped: Post treatment
Descripción

Concomitant Medication End Date

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2826744
Date stopped
Descripción

Concomitant Medication End Date

Tipo de datos

date

Alias
UMLS CUI [1]
C2826744
Volver a la parte superior de la página

Similar models

Concomitant Medications, Tarceva in NSCLC patients who have EGFR-positive tumors NCT00373425

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Concomitant Medications
Concomitant Medication
Item
Concomitant Medication
boolean
C2347852 (UMLS CUI [1])
Item Group
Medications
Concomitant Medication
Item
Medication (Use generic name when possible)
text
C2347852 (UMLS CUI [1])
Indication Prophylaxis
Item
Prophylaxis
boolean
C2826696 (UMLS CUI [1,1])
C0199176 (UMLS CUI [1,2])
Indication
Item
Indication
text
C2826696 (UMLS CUI [1])
Concomitant Medication Start Date
Item
Date started: Prestudy
boolean
C2826734 (UMLS CUI [1])
Concomitant Medication Start Date
Item
Date started
date
C2826734 (UMLS CUI [1])
Concomitant Medication End Date
Item
Date stopped: Post treatment
boolean
C2826744 (UMLS CUI [1])
Concomitant Medication End Date
Item
Date stopped
date
C2826744 (UMLS CUI [1])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial